Universal dx announces strategic collaboration with quest diagnostics to bring advanced colorectal cancer screening blood test to patients and providers in the united states

Udx also announces the initial closing of its series b financing of approximately $70 million with investors, including quest diagnostics financing to support udx's pursuit of fda premarket approval for its colorectal cancer screening blood test cambrdige, mass. and secaucus, n.j.
DGX Ratings Summary
DGX Quant Ranking